Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.7962
-0.0673 (-7.79%)
At close: Jun 6, 2025, 4:00 PM
0.8080
+0.0118 (1.48%)
After-hours: Jun 6, 2025, 7:57 PM EDT
Hyperfine Revenue
Hyperfine had revenue of $2.14M in the quarter ending March 31, 2025, a decrease of -35.14%. This brings the company's revenue in the last twelve months to $11.73M, up 0.34% year-over-year. In the year 2024, Hyperfine had annual revenue of $12.89M with 16.84% growth.
Revenue (ttm)
$11.73M
Revenue Growth
+0.34%
P/S Ratio
4.98
Revenue / Employee
$105,694
Employees
111
Market Cap
61.98M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
HYPR News
- 4 days ago - Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality - Business Wire
- 9 days ago - Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System - Business Wire
- 22 days ago - Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference - Business Wire
- 24 days ago - Hyperfine, Inc. (HYPR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Hyperfine, Inc. Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025 - Business Wire
- 7 weeks ago - Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices - Business Wire
- 2 months ago - Hyperfine, Inc. (HYPR) Q4 2024 Earnings Call Transcript - Seeking Alpha